Skip to main content
OpenTrials

Clinical trial condition

Syndactyly

Explore clinical trials studying Syndactyly. Study availability and eligibility vary by location and protocol.

23 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Syndactyly trial results

Completed

A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)

NCT02872714

Conditions
Acrocephalosyndactylia, Bone Diseases, Bone Diseases, Developmental, +16 more
Locations
  • Arizona Oncology Associates (Wilmot) Tucson, Arizona, United States
  • Sharp Memorial Hospital San Diego, California, United States
  • UCSF Helen Diller Family Comprehensive Care Center San Francisco, California, United States
  • Rocky Mountain Cancer Centers Boulder, Colorado, United States
View all 96 locations
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration

NCT05253807

Conditions
Acrocephalosyndactylia, Bone Diseases, Bone Diseases, Developmental, +25 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Florida Cancer Specialists & Research Institute Fort Myers, Florida, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Memorial Healthcare System Pembroke Pines, Florida, United States
View all 36 locations
View Trial Details
Completed

A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or Cholangiocarcinoma

NCT02699606

Conditions
Acrocephalosyndactylia, Adenocarcinoma, Bone Diseases, +33 more
Locations
  • Beijing, China
  • Harbin, China
  • Nanjing, China
  • Seoul, South Korea
View Trial Details
Completed

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Participants With Advanced or Refractory Solid Tumors or Lymphoma

NCT01703481

Conditions
Acrocephalosyndactylia, Bone Diseases, Bone Diseases, Developmental, +29 more
Locations
  • Birmingham, Alabama, United States
  • Tucson, Arizona, United States
  • La Jolla, California, United States
  • Los Angeles, California, United States
View all 37 locations
View Trial Details
Completed

Derazantinib and Atezolizumab in Patients With Urothelial Cancer

NCT04045613

Conditions
Acrocephalosyndactylia, Bone Diseases, Bone Diseases, Developmental, +26 more
Locations
  • CTCA Clinical Research Inc., Atlanta Newnan, Georgia, United States
  • Englander Institute Weill Cornell Medicine New York, United States
  • New York Cancer and Blood Specialists Port Jefferson Station, New York, United States
  • University of Texas Southwestern Medical Center (UTSWMC) Dallas, Texas, United States
View all 66 locations
View Trial Details
Completed

A Study to Identify Participants With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations

NCT03955913

Conditions
Acrocephalosyndactylia, Bone Diseases, Bone Diseases, Developmental, +12 more
Locations
  • Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Medical Oncology Hematology Consultants, PA Newark, Delaware, United States
  • Affiliated Oncologists, LLC Chicago Ridge, Illinois, United States
View all 199 locations
View Trial Details
Completed

Phase 1b Trial of BGJ398/BYL719 in Solid Tumors

NCT01928459

Conditions
Acrocephalosyndactylia, Advanced Solid Tumors, Bone Diseases, +18 more
Locations
  • H. Lee Moffitt Cancer Center & Research Institute Moffitt 4 Tampa, Florida, United States
  • University of Michigan Comprehensive Cancer Center SC Ann Arbor, Michigan, United States
  • Karmanos Cancer Institute Dept of Onc Detroit, Michigan, United States
  • Washington University School of Medicine Onc Dept St Louis, Missouri, United States
View all 22 locations
View Trial Details

Related conditions